These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14196399)

  • 21. INFLUENCE OF BOTH HORMONAL AND ALKYLATING DRUGS ON FOLLICLE-STIMULATION FUNCTION OF THE PITUITARY.
    BELOVA MG; VALUJEVA IM
    Acta Unio Int Contra Cancrum; 1964; 20():427-8. PubMed ID: 14151951
    [No Abstract]   [Full Text] [Related]  

  • 22. [Local treatment of carcinomatous effusions with triethylenethiophosphoramide (thio-tepa)].
    Schwandt P; Ehrhart H
    Munch Med Wochenschr; 1966 Dec; 108(50):2535-40. PubMed ID: 4166193
    [No Abstract]   [Full Text] [Related]  

  • 23. [MEDULLARY APLASIA DURING THE USE OF 4 ANTIMITOTICS: CARYOLYSIN, MYLERAN, THIOTEPA, ENDOXAN (APROPOS OF 32 CASES)].
    PLAUCHU M; DALMAIS J; GUINGAND M
    J Med Lyon; 1963 Dec; 44():1811-65. PubMed ID: 14126897
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined chemotherapy in the treatment of malignant effusions.
    MacGregor AB; Macleod DA; Thomson JW
    Br J Surg; 1969 Jul; 56(7):489-91. PubMed ID: 4978527
    [No Abstract]   [Full Text] [Related]  

  • 25. [TERATOGENIC EFFECT OF A COMBINATION OF FASTING AND THIO-TEPA ADMINISTRATION IN PREGNANT MICE].
    NISHIKAWA M
    Kaibogaku Zasshi; 1964 Dec; 39():252-7. PubMed ID: 14277859
    [No Abstract]   [Full Text] [Related]  

  • 26. [MATERNAL AGE OF MICE AND THE ADMINISTRATION OF THIO-TEPA DURING PREGNANCY AS RELATED TO THE MALFORMATION OF THE FETUS].
    NANJO H
    Kaibogaku Zasshi; 1964 Dec; 39():258-62. PubMed ID: 14277860
    [No Abstract]   [Full Text] [Related]  

  • 27. INFLUENCE OF ALKYLATING AGENTS ON KIDNEY ERYTHROPOIETIN PRODUCTION.
    FISHER JW; ROH BL
    Cancer Res; 1964 Jul; 24():983-8. PubMed ID: 14195351
    [No Abstract]   [Full Text] [Related]  

  • 28. [PALLIATIVE TREATMENT OF CANCERS WITH THIO-TEPA. STUDY OF 115 CASES. VALUE IN BREAST CANCERS].
    LAGARDE C; HIRTZ G; HUGUES A; CHAUVERGNE J; HOERNI B
    Presse Med (1893); 1964 Sep; 72():2285-90. PubMed ID: 14186332
    [No Abstract]   [Full Text] [Related]  

  • 29. THE COMBINED THIOTEPA AND TESTOSTERONE TREATMENT OF CANCER OF THE BREAST.
    BROWN IS; ROSS WM; WALDER DN
    Br J Cancer; 1964 Jun; 18(2):238-46. PubMed ID: 14189677
    [No Abstract]   [Full Text] [Related]  

  • 30. MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE.
    GOLDMAN BS; PEARSON FG
    Can J Surg; 1965 Apr; 8():157-61. PubMed ID: 14280322
    [No Abstract]   [Full Text] [Related]  

  • 31. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
    KONDO T
    Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882
    [No Abstract]   [Full Text] [Related]  

  • 32. ANTITUMOR ACTIVITY OF PHOSPHAZINE.
    CHERNOV VA; GRUSHINA AA; LYTKINA LT
    Fed Proc Transl Suppl; 1964; 23():39-42. PubMed ID: 14112003
    [No Abstract]   [Full Text] [Related]  

  • 33. Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome.
    Riker D; Goba D
    J Bronchology Interv Pulmonol; 2013 Jan; 20(1):48-51. PubMed ID: 23328144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant effusions.
    Malden LT; Tattersall MH
    Q J Med; 1986 Mar; 58(227):221-39. PubMed ID: 3526384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCREENING TEST FOR CYTOTOXIC AGENTS ON TUMOR PRIMARY CELL CULTURES.
    COSTAKEL O; FADEI L; NACHTIGAL M
    Neoplasma; 1963; 10():565-9. PubMed ID: 14103643
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE COMBINED ACTION OF THIO-TEPA, OMAIN (COLCHAMINE) AND SOME HORMONAL PREPARATIONS ON THE EPTHELIUM OF THE UTERINE CERVIX AND VAGINA IN MICE].
    GRINVALD VA; KOSOI GKh
    Biull Eksp Biol Med; 1964 Jun; 57():96-9. PubMed ID: 14233000
    [No Abstract]   [Full Text] [Related]  

  • 37. (OUR EXPERIENCE IN USING THIOTEPA IN ONCOLOGICAL HOSPITALS.).
    KUNDZINYA I; TSEPLITT R; POORKALN T; AUZINYA A
    Acta Unio Int Contra Cancrum; 1964; 20():360-2. PubMed ID: 14151929
    [No Abstract]   [Full Text] [Related]  

  • 38. [COMPARATIVE EVALUATION OF METHODS OF TREATING PATIENTS WITH FAR ADVANCED MALIGNANT OVARIAN NEOPLASMS].
    NECHAEVA ID
    Vopr Onkol; 1963; 9():23-30. PubMed ID: 14105954
    [No Abstract]   [Full Text] [Related]  

  • 39. REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU.
    GREENSPAN EM
    N Y State J Med; 1964 Oct; 64():2442-9. PubMed ID: 14209557
    [No Abstract]   [Full Text] [Related]  

  • 40. CARCINOMA OF THE OVARY.
    LEBHERZ TB; PARKER RT
    Am J Obstet Gynecol; 1965 Sep; 93():136-41. PubMed ID: 14329163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.